Cancer Research: #RadicalCollaboration

Break Through Cancer empowers outstanding researchers and physicians to both intercept and find cures for the deadliest cancers by stimulating radical collaboration.

Empowers

Break Through Cancer is committed to reducing the day-to-day barriers to cross-institutional collaboration such as contract negotiations, data sharing, intellectual property, and authorship policies.

Outstanding Researchers and Physicians

Break Through Cancer is a first-of-its-kind collaboration of five of the top cancer research centers in the world: Dana-Farber Cancer Institute, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, MIT’s Koch Institute for Integrative Cancer Research, The University of Texas MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center.

deadliestcancers

Break Through Cancer is focused on several of the world’s deadliest cancers. These are diseases with poor prognoses for which progress has been very slow.

Radicalcollaboration

Radical collaboration is the expectation of all Break Through Cancer researchers, physicians, and other partners. Radical collaboration requires sharing discoveries and data in real time, a trust and willingness to critique each other’s ideas, and a sense of urgency knowing that lives are at stake.

IT’S ALL ABOUT THE PEOPLE

abstract laboratory medical background. petri dishes, test tubes

David A. Reardon, MD

“Break Through Cancer is a unique opportunity for some of the leading cancer researchers and clinicians to come together and pool their experiences, and to work together to accelerate developments, advances, and ultimately improvement and outcome for our patients”

Learn More

Dana-Farber Cancer Institute

Accelerating GBM Therapies Through Serial Biopsies

Anirban Maitra, MBBS

"Break Through Cancer is a completely novel and innovative way of doing cancer research where instead of doing this as a single institution or a single lab, you bring together institutions across the spectrum with varying expertise, different disciplines, all come together as a single entity focused on the hardest questions in cancer."

Learn More

The University of Texas MD Anderson Cancer Center

Conquering KRAS in Pancreatic Cancer

Abstract nano molecular structure. Water 3d spheres

Paola A. Guerrero, PhD

“I guess for me, radical collaboration is when you can actually push boundaries and take a risk based on thinking what is the best for, for research”

Learn More

The University of Texas MD Anderson Cancer Center

Conquering KRAS in Pancreatic Cancer

Laura D. Wood, MD, PhD

Learn More

"The TeamLab is really unique and different from anything that I've done in the past. In particular, the multi-institutional and collaborative nature and the broad expertise in the TeamLab. I think it's the diversity of the TeamLab, the breadth of expertise, and having all of those voices together in one room to really try to solve big problems."

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Leveraging Spatial Technology to Demystify Pancreatic Cancer Therapies in Patients

Kara Long, MD, MSc

“This endeavor has allowed us to think bigger and in a different way...it gave us the, the voice to use creativity and think big to try to come up with a plan that's gonna actually keep people from getting cancer in our lifetimes”

Memorial Sloan Kettering Cancer Center

Intercepting Ovarian Cancer

Learn More

Andrew Lane, MD, PhD

“We have clinicians, scientists, clinicians who don't ever see a pipette. We have scientists who don't ever see a patient,and everybody has a seat at the table and everybody's ideas count... So that is a bit radical compared to the way we usually do business”

Dana-Farber Cancer Institute

Identifying, Understanding and Eradicating Measurable Residual Disease in Patients with Acute Myeloid Leukemia

Learn More

Kenny Yu, MBBS, PhD, FRCS

"It's like an experiment in radical team science. I think it's unusual to have so much talent and expertise put into one place towards a single purpose. And for us, all of us deal with brain cancer all the time, and I think having the singular mission is what defines this team, and it's really been a privilege to be part of."

Memorial Sloan Kettering Cancer Center

Accelerating GBM Therapies Through Serial Biopsies

Learn More

Jessica Lin, MD

"There’s a ceiling to how much can be achieved, and at what pace, with single isolated institutions. But when multiple centers that are sharing the same goal come together to make progress we can advance the science in a really transformative way."

Massachusetts General Hospital

PoweRD 2 Cure ALK+ Lung Cancer

Learn More

Koichi Takahashi, MD, PhD

Learn More

"There are lots of advantages in interacting with other peoples and other institutions. Number one is that there's a limit of what you can do by one person. And number two, just by talking with someone whose background is different, you get new ideas..it creates ideas and the foundation for the discovery"

The University of Texas MD Anderson Cancer Center

Targeting Clonal Hematopoiesis to Prevent Acute Myeloid Leukemia

UPDATES AND NEWS

Press Release

December 18, 2024February 6, 2025

Break Through Cancer and Revolution Medicines Collaborate to Study Biomarkers for RAS(ON) Inhibitor in Pancreatic Cancer

News

December 6, 2024February 7, 2025

New collaborative effort aims to cure ALK-positive lung cancer | News Medical

News

December 6, 2024February 7, 2025

Break Through Cancer launches the PoweRD 2 Cure ALK+ Lung Cancer TeamLab | The Cancer Letter

Press Release

December 5, 2024January 6, 2025

Break Through Cancer Launches Team to Prevent Lung Cancer Recurrence with the Hope of Long-term Cures.

View All

BE PART OF THE MISSION
Stay Informed, Make an Impact

Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.

Give

Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 709.